You have read all your free articles, to continue reading subscribe to read the rest of this content.
SynAct Pharma has announced that its share started trading on Nasdaq Stockholm’s main list July 12, 2022. “SynAct Pharma has worked hard with its pipeline to make it to where it is today. To be traded on the main market is an important landmark and a stamp of quality for…
The Swedish Agency for Economic and Regional Growth has awarded Umeå Biotech Incubator (UBI) a grant of SEK 9.5 million. For the next 18 months, Umeå Biotech Incubator (UBI) will develop meeting places and create the conditions for the continued growth of the life science industry in northern SAlready a…
OssDsign has received 510(k) clearance by the US FDA for marketing of OSSDSIGN Cranial PSI in the USA. “Receiving FDA clearance for our flagship product OSSDSIGN Cranial is extremely positive news. This means we can continue working according to our existing plan of launching OSSDSIGN Cranial oAlready a subscriber Login…
Nanoform and Celanese Corporation have announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery. The goal is to assess the utility of combining Nanoform’s nanoparticle platform technologies with Celanese’s VitalDose EVA Already a subscriber Login You have read all your free articles,…
